Loading clinical trials...
Loading clinical trials...
The voice is a reflection of our identity. In the case of transgender women, there may be a gap between perceived male voice and female appearance. Indeed, hormonal treatment in transgender women has no effect on the voice quality. This gap can have negative consequences on everyday life in banal situations such as telephonic contact leading to limited use of phone calls and social isolation. Differences between female and male voices seem to be socially determined and do not depend directly on sexual dimorphism of the phonatory organs. Speech therapy might thus be indicated as a vocal support for transgender women. Only few studies have examined the impact of perceived voice on the quality of life of transgender women.
Age
18 - No limit years
Sex
MALE
Healthy Volunteers
No
University Hospital Nancy
Vandœuvre-lès-Nancy, France
Start Date
February 28, 2019
Primary Completion Date
March 5, 2020
Completion Date
March 5, 2020
Last Updated
July 25, 2022
77
ACTUAL participants
Lead Sponsor
Central Hospital, Nancy, France
NCT07252687
NCT07147166
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions